The role of nuclear receptors PXR/CAR in the pathogenesis of inflammatory bowel diseases.
Project/Area Number |
25460941
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Gunma University |
Principal Investigator |
Kakizaki Satoru 群馬大学, 大学院医学系研究科, 講師 (80344935)
|
Co-Investigator(Kenkyū-buntansha) |
山崎 勇一 群馬大学, 医学部附属病院, 助教 (00582404)
堀口 昇男 群馬大学, 医学部附属病院, 助教 (10550022)
|
Co-Investigator(Renkei-kenkyūsha) |
YOSHINARI Kouichi 静岡県立大学, 大学院薬学系研究科, 教授 (60343399)
|
Research Collaborator |
TAKIZAWA Daichi 群馬大学, 大学院医学系研究科, 大学院生
TOJIMA Hiroki 群馬大学, 大学院医学系研究科, 大学院生
TAHARA Hiroki 群馬大学, 大学院医学系研究科, 大学院生
|
Project Period (FY) |
2013-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 炎症性腸疾患 / 核内レセプター / PXR / CAR / DSS腸炎 / 炎症性サイトカイン / CAR / PXR / DSS腸炎 / 核内受容体 |
Outline of Final Research Achievements |
The aim of this study was to investigate the role of nuclear receptors PXR and CAR in the pathogenesis of inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease. Wild-type, Pxr-null, Car-null, and Pxr/Car-double null mice were treated with a PXR/CAR agonist or vehicle in a dextran sodium sulfate (DSS)-induced IBD model. PXR and CAR ameliorate DSS-induced ulcerative colitis model via inhibiting inflammatory cytokines and apoptosis.PXR and CAR agonists are promising agents for the treatment of IBD.
|
Report
(5 results)
Research Products
(13 results)
-
-
[Journal Article] A prospective randomized controlled trial of AJG522 versus standard PEG+E as bowel preparation for colonoscopy.2015
Author(s)
Sagawa T, Sato K, Tomizawa T, Mizuide M, Yasuoka H, Shimoyama Y, Kuribayashi S, Kakizaki S, Kawamura O, Kusano M, Yamada M.
-
Journal Title
Biomed Res Int.
Volume: 2015
Pages: 521746-521746
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor2014
Author(s)
Yoshino S, Satoh T, Yamada M, Hashimoto K, Tomaru T, Katano-Toki A, Kakizaki S, Okada S, Shimizu H, Ozawa A, Tuchiya T, Ikota H, Nakazato Y, Mori M, Matozaki T, Sasaki T, Kitamura T, Mori M.
-
Journal Title
Endocrinology.
Volume: 155
Issue: 9
Pages: 3459-3472
DOI
Related Report
Peer Reviewed
-
[Journal Article] Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.2014
Author(s)
Namikawa M, Kakizaki S, Kaira K, Tojima H, Yamazaki Y, Horiguchi N, Sato K, Oriuchi N, Tominaga H, Sunose Y, Nagamori S, Kanai Y, Oyama T, Takeyoshi I, Yamada M.
-
Journal Title
Hepatol Res.
Volume: in press
Issue: 9
Pages: 1014-1022
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.2014
Author(s)
Ohyama T, Sato K, Yamazaki Y, Hashizume H, Horiguchi N, Kakizaki S, Mori M, Kusano M, Yamada M.
-
Journal Title
World J Gastroenterol
Volume: 20
Issue: 43
Pages: 16227-35
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Transforming growth factor-α activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation.2013
Author(s)
Tahara H, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Hashizume H, Kakizaki S, Takagi H, Ozaki I, Arai H, Hirato J, Jesenofsky R, Masamune A, Mori M.
-
Journal Title
Lab Invest
Volume: 93
Pages: 720-732
DOI
Related Report
Peer Reviewed
-
-
-
-
-